Turning Point Therapeutics, Inc. Retained Earnings
Turning Point Therapeutics, Inc. had Retained Earnings of -$714.26 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-08-08
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$714.26M.
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$591.17M.
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$516.73M.
- 2021-09-30: Retained Earnings (Accumulated Deficit) -$438.28M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2022-06-30 | -$714.26M 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$591.17M 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$516.73M 10-Q · filed 2022-08-08 |
| 2021-09-30 | -$438.28M 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$371.95M 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$315.68M 10-Q · filed 2021-05-05 |
| 2020-12-31 | -$280.18M 10-K · filed 2022-02-28 |
| 2020-09-30 | -$232.80M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$215.09M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$183.60M 10-Q · filed 2020-05-12 |
| 2019-12-31 | -$122.88M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$101.92M 10-Q · filed 2019-11-04 |
| 2019-06-30 | -$81.44M 10-Q · filed 2019-08-06 |
| 2019-03-31 | -$64.30M 10-Q · filed 2019-05-31 |
| 2018-12-31 | -$50.75M 10-K · filed 2020-03-18 |